Michelle Averill, PhD

Lecturer, Env. and Occ. Health Sciences (Primary department)
Dr. Averill received her PhD in Nutritional Sciences from the University of Washington and she now both lectures and researches in the field of nutrition, obesity, and diabetes. Dr. Averill is the clinical coordinator for the Graduate Coordinated Program in Dietetics at the University of Washington and she is a member of several professional organizations, including the American Society of Parenteral and Enteral Nutrition and the Academy of Nutrition and Dietetics.

Contact Information

Office: Raitt 324A
Box: 353410
Tel: 206-221-6554

Research Interests

  • Etiology of obesity associated disorders, Atherosclerosis and insulin resistance, Macrophage biology and inflammation, Atherosclerosis progression, Cardiovascular disease, Lipid and glucose metabolism, Diet-environment interaction and health outcomes, Socio-economic status diet-related health outcomes and obesity, and the effect of diet composition on lipids

Teaching interests

Nutr 562 Acute Care Nutrition
Nutr 559 Orientation to Clinical Practice
Nutr 511 Survey of Advanced Nutrition
Nutr 310 Nutrition Across the Life Course


PhD, Nutritional Science, University of Washington, 2007


Diet and HDL Composition: the effect of a high fat versus a high carbohydrate meal on the proteome and lipidome in the postprandial state. Urinary sodium-to-potassium ratio and CVD: Study looking at the relationship between sodium and potassium with CVD endpoints, using urinary measures as biomarkers of dietary intake in the Multi-Ethnic Study of Atherosclerosis (MESA) cohort. Whole Food Tube Feeding Study: pilot randomized controlled trial comparing standard versus whole foods based enteral nutrition formulas in patients undergoing surgery for head and neck cancer. Achievement gap study: determining the extent of an achievement gap in an undergraduate public health science course.
Selected Publications

1. Averill MM, Bornfeldt KB. Lipids versus glucose in inflammation and the pathogenesis of macrovascular disease in diabetes. Current Diabetes Reports. 2009 Feb;9(1):18-25

2. Averill MM, Kerkhoff C, Bornfeldt KE. S100A8 and S100A9 in cardiovascular biology and disease. Arterioscler Thromb Vasc Biol. 2012 Feb;32(2):223-9

3. Averill MM, Barnhart S, Becker L, Li X, Heinecke JW, Leboeuf RC, Hamerman JA, Sorg C, Kerkhoff C, Bornfeldt KE. S100A9 differentially modifies phenotypic states of neutrophils, macrophages, and dendritic cells: implications for atherosclerosis and adipose tissue inflammation. Circulation. 2011 Mar 22;123(11):1216-26.

4. Averill M, Kim EJ, Goodspeed L, Wang S, Subramanian S, den Hartigh L, Tang C, Ding Y, Reardon C, Getz G, Chait A: The apolipoprotein-AI mimetic peptide L4F at a modest dose does not attenuate weight gain, inflammation, or atherosclerosis in LDLR-null mice. PLoS One, in press, 2014. PMCID: PMC4186861

Review date: